KN3835 for Hammer Toe
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.
Who Is on the Research Team?
Medical Director, MD
Principal Investigator
Endo USA Inc., a Keenova Therapeutics Company
Are You a Good Fit for This Trial?
This trial is for people with flexible or semi-flexible hammertoe who do not have other significant foot problems. Women must not be pregnant or breastfeeding and should use effective birth control if they could become pregnant. Participants need to be able to attend all study visits.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- KN3835
Trial Overview
The study compares a new treatment called KN3835 against a placebo (inactive substance) to see how well it works and how safe it is for treating flexible/semi-flexible hammertoe. Participants are randomly assigned to receive either KN3835 or the placebo.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Endo USA Inc., a Keenova Therapeutics Company
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.